183 related articles for article (PubMed ID: 28791425)
41. Pim-1 regulates RANKL-induced osteoclastogenesis via NF-κB activation and NFATc1 induction.
Kim K; Kim JH; Youn BU; Jin HM; Kim N
J Immunol; 2010 Dec; 185(12):7460-6. PubMed ID: 21068407
[TBL] [Abstract][Full Text] [Related]
42. Mitogen- and stress-activated protein kinase 1 activates osteoclastogenesis in vitro and affects bone destruction in vivo.
Ha J; Kim HJ; Huang H; Lee ZH; Kim HH
J Mol Med (Berl); 2013 Aug; 91(8):977-87. PubMed ID: 23619911
[TBL] [Abstract][Full Text] [Related]
43. Necrostatin-7 suppresses RANK-NFATc1 signaling and attenuates macrophage to osteoclast differentiation.
Fuji H; Ohmae S; Noma N; Takeiri M; Yasutomi H; Izumi K; Ito M; Toyomoto M; Iwaki S; Takemoto K; Seo S; Taura K; Hida S; Aoyama M; Ishihama Y; Hagiwara M; Takeda N; Hatano E; Iwaisako K; Uemoto S; Asagiri M
Biochem Biophys Res Commun; 2018 Sep; 503(2):544-549. PubMed ID: 29800570
[TBL] [Abstract][Full Text] [Related]
44. G Protein-Coupled Receptor 120 Signaling Negatively Regulates Osteoclast Differentiation, Survival, and Function.
Kim HJ; Yoon HJ; Kim BK; Kang WY; Seong SJ; Lim MS; Kim SY; Yoon YR
J Cell Physiol; 2016 Apr; 231(4):844-51. PubMed ID: 26280807
[TBL] [Abstract][Full Text] [Related]
45. Zinc inhibits osteoclast differentiation by suppression of Ca2+-Calcineurin-NFATc1 signaling pathway.
Park KH; Park B; Yoon DS; Kwon SH; Shin DM; Lee JW; Lee HG; Shim JH; Park JH; Lee JM
Cell Commun Signal; 2013 Oct; 11():74. PubMed ID: 24088289
[TBL] [Abstract][Full Text] [Related]
46. Orostachys japonicus Suppresses Osteoclast Differentiation by Inhibiting NFATc1 Expression.
Shim KS; Ha H; Kim T; Lee CJ; Ma JY
Am J Chin Med; 2015; 43(5):1013-30. PubMed ID: 26205967
[TBL] [Abstract][Full Text] [Related]
47. Ca
Grössinger EM; Kang M; Bouchareychas L; Sarin R; Haudenschild DR; Borodinsky LN; Adamopoulos IE
J Immunol; 2018 Jan; 200(2):749-757. PubMed ID: 29246953
[TBL] [Abstract][Full Text] [Related]
48. RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation.
Sundaram K; Nishimura R; Senn J; Youssef RF; London SD; Reddy SV
Exp Cell Res; 2007 Jan; 313(1):168-78. PubMed ID: 17084841
[TBL] [Abstract][Full Text] [Related]
49. RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway.
Iwai K; Koike M; Ohshima S; Miyatake K; Uchiyama Y; Saeki Y; Ishii M
J Bone Miner Res; 2007 Oct; 22(10):1612-20. PubMed ID: 17576169
[TBL] [Abstract][Full Text] [Related]
50. Rab27a and Rab27b are involved in stimulation-dependent RANKL release from secretory lysosomes in osteoblastic cells.
Kariya Y; Honma M; Hanamura A; Aoki S; Ninomiya T; Nakamichi Y; Udagawa N; Suzuki H
J Bone Miner Res; 2011 Apr; 26(4):689-703. PubMed ID: 20939018
[TBL] [Abstract][Full Text] [Related]
51. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
[TBL] [Abstract][Full Text] [Related]
53. Kirenol inhibits RANKL-induced osteoclastogenesis and prevents ovariectomized-induced osteoporosis via suppressing the Ca
Zou B; Zheng J; Deng W; Tan Y; Jie L; Qu Y; Yang Q; Ke M; Ding Z; Chen Y; Yu Q; Li X
Phytomedicine; 2021 Jan; 80():153377. PubMed ID: 33126167
[TBL] [Abstract][Full Text] [Related]
54. NIP45 negatively regulates RANK ligand induced osteoclast differentiation.
Shanmugarajan S; Haycraft CJ; Reddy SV; Ries WL
J Cell Biochem; 2012 Apr; 113(4):1274-81. PubMed ID: 22105856
[TBL] [Abstract][Full Text] [Related]
55. IRF2 enhances RANKL-induced osteoclast differentiation via regulating NF-κB/NFATc1 signaling.
Kim I; Kim JH; Kim K; Seong S; Lee KB; Kim N
BMB Rep; 2021 Sep; 54(9):482-487. PubMed ID: 34488926
[TBL] [Abstract][Full Text] [Related]
56. Genetic and pharmacological activation of Hedgehog signaling inhibits osteoclastogenesis and attenuates titanium particle-induced osteolysis partly through suppressing the JNK/c-Fos-NFATc1 cascade.
Zhang L; Yang Y; Liao Z; Liu Q; Lei X; Li M; Saijilafu ; Zhang Z; Hong D; Zhu M; Li B; Yang H; Chen J
Theranostics; 2020; 10(15):6638-6660. PubMed ID: 32550895
[No Abstract] [Full Text] [Related]
57. Cysteine proteinase inhibitors regulate human and mouse osteoclastogenesis by interfering with RANK signaling.
Strålberg F; Henning P; Gjertsson I; Kindlund B; Souza PP; Persson E; Abrahamson M; Kasprzykowski F; Grubb A; Lerner UH
FASEB J; 2013 Jul; 27(7):2687-701. PubMed ID: 23572233
[TBL] [Abstract][Full Text] [Related]
58. Carboxypeptidase E is a novel modulator of RANKL-induced osteoclast differentiation.
Kim HJ; Hong J; Yoon HJ; Yoon YR; Kim SY
Mol Cells; 2014 Sep; 37(9):685-90. PubMed ID: 25220258
[TBL] [Abstract][Full Text] [Related]
59. Lhx2 regulates bone remodeling in mice by modulating RANKL signaling in osteoclasts.
Kim JH; Youn BU; Kim K; Moon JB; Lee J; Nam KI; Park YW; O'Leary DD; Kim KK; Kim N
Cell Death Differ; 2014 Oct; 21(10):1613-21. PubMed ID: 24902903
[TBL] [Abstract][Full Text] [Related]
60. Total saponin from Anemone flaccida Fr. Schmidt abrogates osteoclast differentiation and bone resorption via the inhibition of RANKL-induced NF-κB, JNK and p38 MAPKs activation.
Kong X; Wu W; Yang Y; Wan H; Li X; Zhong M; Zhao H; Su X; Jia S; Ju D; Lin N
J Transl Med; 2015 Mar; 13():91. PubMed ID: 25889035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
